Jobs / United States / Astrazeneca Pharmaceuticals Lp
Senior Director, AI Commercial Business Partner - Europe & Canada
Astrazeneca Pharmaceuticals Lp · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Role: Senior Director, AI Commercial Business Partner - Europe & Canada Location: Cambridge UK or Barcelona Spain Salary: Competitive + Excellent Benefits Do you have an organizational mindset and -can-do attitude that enables you to deliver positive outcomes on high impact and complex AI projects? Are you looking to join a growing team that will design and deliver value-driven change to an organization, do you relish the opportunity to drive wide scale commercial innovation across teams and lead the AI revolution in commercial for AstraZeneca. About AstraZeneca: At AstraZeneca, we are proud of our ground-breaking pipeline and continue to look for new ways to bring the best medicines to patients. We are building and fostering high-performing collaborative teams across the organization to help us deliver on our ambition. There’s no better time to join our global, growing enterprise as we lead the way for patients, healthcare and broader society. AI Commercial Team (AIC): The AI Commercial team, is part of the newly founded Enterprise AI team (EAI), delivering AI strategy and coordinated commercial progress and programs, in close collaboration with our business teams, and in partnership with our enterprise teams. We lead cross-functional and commercial-wide initiatives to deliver transformative commercial value and ensure we are at our best in delivering lifesaving medicines to patients. What you’ll do: AI Commercial Business Leaders are the embedded “translators” between business functions and the AI Commercial organization, responsible for the success of AI programs. The role is strategically positioned in therapy areas, markets, and functions with the objectives to drive translation, adoption, and lifecycle management of AI solutions in the business. Key deliverables include translating business needs into well-scoped AI use cases and ensure each solution delivers measurable business impact. This requires you to be bilingual in business/science and technology, enabling you to connect domain priorities with AI delivery teams. You will be responsible for owning the full lifecycle of AI solutions - from ideation through delivery, adoption, and decommissioning - and are accountable for driving real, sustained value and reuse. In this role, you will be responsible for building the bridge between business teams at a Region and Market level, and technical experts within the AIC and EAI function as well as key other Enterprise technology teams such as Commercial IT and Global Business Services. As part of this role, you will champion the key commercial AI programs in service of enhancing customer engagement, powered by actionable AI insights, delivered thought agentic platforms. In addition, you will partner on the delivery of AI capability building programs. To do this successfully, you will share geographic location with the respective Region team, have a seat at the Senior leader table for the Region, with connection further enhanced through dotted line reporting to the Region, while sitting on the AIC Leadership team reporting to VP AIC. Oncology Business Unit (OBU) is responsible for the commercialisation of medicines across some of the most hard-to-treat forms of disease, including: lung, breast, gastrointestinal, gynaecological, genitourinary and haematology cancers. Responsibilities include: • Strategy and portfolio ownership of new AI Commercial programs for in partnership with the business teams. • Single point of contact and responsible for engagement for AI Commercial capabilities programs for the Region, maintaining AI roadmaps aligned with business needs, developing business cases in partnership with the business, and promoting reuse principles. • Translation of needs into AI use cases: Engaging with stakeholders